Kaiser Permanente · Zepbound and Wegovy coverage

Does Kaiser Permanente cover Zepbound or Wegovy?

Last updated

It depends on the region; in California, at a BMI of 40 or more unless a rider is bought.

If it is not covered: the lowest cash prices now

  • Without insurance: compounded tirzepatide on a monthly plan, not FDA-approved

    Collective

    $69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

  • Without insurance: compounded semaglutide on a monthly plan, not FDA-approved

    Collective

    $59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

It depends on the region; in California, at a BMI of 40 or more unless a rider is bought. Kaiser Permanente California removed weight-loss-only GLP-1 coverage from base commercial and individual plans at renewals from January 1, 2025 for members with a BMI under 40. In its words: "Effective with contract renewal on or after January 1, 2025, coverage for GLP-1 drugs and other AOMs will be removed from base coverage in California commercial and Individual & Family plans when those drugs are prescribed solely for the purpose of weight loss for patients with BMI less than 40." (Kaiser Permanente California employer news, Changes for GLP-1 drugs & other Anti-Obesity Medications in 2025 (Wayback Machine copy of 2025-10-18; the live page answers 404 on 2026-11-17), web.archive.org, read Nov 17, 2026). In California, Kaiser Permanente still covers GLP-1s under the base plan at a BMI of 40 or more and when prescribed in a disease management program such as for type 2 diabetes or a major adverse cardiac event. In its words: "Per California Title 28 Rule 1300.67.24(e)(3), GLP-1 drugs and other AOMs will still be covered under the base plan for patients with BMI equal to or greater than 40. Coverage remains unchanged for GLP-1’s and other AOMs, when prescribed as part of a disease management program for medical conditions (for example, Type 2 Diabetes or Major Adverse Cardiac Event)." (Kaiser Permanente California employer news, Changes for GLP-1 drugs & other Anti-Obesity Medications in 2025 (Wayback Machine copy of 2025-10-18; the live page answers 404 on 2026-11-17), web.archive.org, read Nov 17, 2026). Large employers in California can buy a Kaiser Permanente weight-loss drug rider to cover GLP-1s for weight loss more broadly. In its words: "Broader coverage for GLP-1s and other AOMs for patients without comorbidities or increased disease risk that are prescribed solely for the purpose of weight loss can be made available through purchase of an additional weight loss drug rider by large group plan sponsors." (Kaiser Permanente California employer news, Changes for GLP-1 drugs & other Anti-Obesity Medications in 2025 (Wayback Machine copy of 2025-10-18; the live page answers 404 on 2026-11-17), web.archive.org, read Nov 17, 2026). Kaiser Permanente Northwest (Oregon and SW Washington) covers Wegovy for weight loss only for members whose plan covers weight-loss drugs, as a non-formulary drug after two oral drugs and Ozempic have failed; others pay the cash price. In its words: "Wegovy is covered under the prescription drug benefit for weight loss ONLY for Kaiser Northwest members with coverage for medications used to treat weight loss. Others pay member cash price." (Kaiser Permanente Northwest Region criteria for coverage, semaglutide (Wegovy), commercial, revised 12/11/25, effective 02/05/26, healthy.kaiserpermanente.org, Feb 5, 2026, read Nov 17, 2026).

Questions

Kaiser Permanente, Zepbound and Wegovy: common questions

Does Kaiser Permanente cover Zepbound for weight loss?

It depends on the region; in California, at a BMI of 40 or more unless a rider is bought. Kaiser Permanente California removed weight-loss-only GLP-1 coverage from base commercial and individual plans at renewals from January 1, 2025 for members with a BMI under 40. In its words: "Effective with contract renewal on or after January 1, 2025, coverage for GLP-1 drugs and other AOMs will be removed from base coverage in California commercial and Individual & Family plans when those drugs are prescribed solely for the purpose of weight loss for patients with BMI less than 40." (Kaiser Permanente California employer news, Changes for GLP-1 drugs & other Anti-Obesity Medications in 2025 (Wayback Machine copy of 2025-10-18; the live page answers 404 on 2026-11-17), web.archive.org, read Nov 17, 2026). In California, Kaiser Permanente still covers GLP-1s under the base plan at a BMI of 40 or more and when prescribed in a disease management program such as for type 2 diabetes or a major adverse cardiac event. In its words: "Per California Title 28 Rule 1300.67.24(e)(3), GLP-1 drugs and other AOMs will still be covered under the base plan for patients with BMI equal to or greater than 40. Coverage remains unchanged for GLP-1’s and other AOMs, when prescribed as part of a disease management program for medical conditions (for example, Type 2 Diabetes or Major Adverse Cardiac Event)." (Kaiser Permanente California employer news, Changes for GLP-1 drugs & other Anti-Obesity Medications in 2025 (Wayback Machine copy of 2025-10-18; the live page answers 404 on 2026-11-17), web.archive.org, read Nov 17, 2026). Large employers in California can buy a Kaiser Permanente weight-loss drug rider to cover GLP-1s for weight loss more broadly. In its words: "Broader coverage for GLP-1s and other AOMs for patients without comorbidities or increased disease risk that are prescribed solely for the purpose of weight loss can be made available through purchase of an additional weight loss drug rider by large group plan sponsors." (Kaiser Permanente California employer news, Changes for GLP-1 drugs & other Anti-Obesity Medications in 2025 (Wayback Machine copy of 2025-10-18; the live page answers 404 on 2026-11-17), web.archive.org, read Nov 17, 2026). Kaiser Permanente Northwest (Oregon and SW Washington) covers Wegovy for weight loss only for members whose plan covers weight-loss drugs, as a non-formulary drug after two oral drugs and Ozempic have failed; others pay the cash price. In its words: "Wegovy is covered under the prescription drug benefit for weight loss ONLY for Kaiser Northwest members with coverage for medications used to treat weight loss. Others pay member cash price." (Kaiser Permanente Northwest Region criteria for coverage, semaglutide (Wegovy), commercial, revised 12/11/25, effective 02/05/26, healthy.kaiserpermanente.org, Feb 5, 2026, read Nov 17, 2026). Zepbound not covered: the cash price at your dose

Does Kaiser Permanente cover Wegovy for weight loss?

It depends on the region; in California, at a BMI of 40 or more unless a rider is bought. Kaiser Permanente California removed weight-loss-only GLP-1 coverage from base commercial and individual plans at renewals from January 1, 2025 for members with a BMI under 40. In its words: "Effective with contract renewal on or after January 1, 2025, coverage for GLP-1 drugs and other AOMs will be removed from base coverage in California commercial and Individual & Family plans when those drugs are prescribed solely for the purpose of weight loss for patients with BMI less than 40." (Kaiser Permanente California employer news, Changes for GLP-1 drugs & other Anti-Obesity Medications in 2025 (Wayback Machine copy of 2025-10-18; the live page answers 404 on 2026-11-17), web.archive.org, read Nov 17, 2026). In California, Kaiser Permanente still covers GLP-1s under the base plan at a BMI of 40 or more and when prescribed in a disease management program such as for type 2 diabetes or a major adverse cardiac event. In its words: "Per California Title 28 Rule 1300.67.24(e)(3), GLP-1 drugs and other AOMs will still be covered under the base plan for patients with BMI equal to or greater than 40. Coverage remains unchanged for GLP-1’s and other AOMs, when prescribed as part of a disease management program for medical conditions (for example, Type 2 Diabetes or Major Adverse Cardiac Event)." (Kaiser Permanente California employer news, Changes for GLP-1 drugs & other Anti-Obesity Medications in 2025 (Wayback Machine copy of 2025-10-18; the live page answers 404 on 2026-11-17), web.archive.org, read Nov 17, 2026). Large employers in California can buy a Kaiser Permanente weight-loss drug rider to cover GLP-1s for weight loss more broadly. In its words: "Broader coverage for GLP-1s and other AOMs for patients without comorbidities or increased disease risk that are prescribed solely for the purpose of weight loss can be made available through purchase of an additional weight loss drug rider by large group plan sponsors." (Kaiser Permanente California employer news, Changes for GLP-1 drugs & other Anti-Obesity Medications in 2025 (Wayback Machine copy of 2025-10-18; the live page answers 404 on 2026-11-17), web.archive.org, read Nov 17, 2026). Kaiser Permanente Northwest (Oregon and SW Washington) covers Wegovy for weight loss only for members whose plan covers weight-loss drugs, as a non-formulary drug after two oral drugs and Ozempic have failed; others pay the cash price. In its words: "Wegovy is covered under the prescription drug benefit for weight loss ONLY for Kaiser Northwest members with coverage for medications used to treat weight loss. Others pay member cash price." (Kaiser Permanente Northwest Region criteria for coverage, semaglutide (Wegovy), commercial, revised 12/11/25, effective 02/05/26, healthy.kaiserpermanente.org, Feb 5, 2026, read Nov 17, 2026). Wegovy not covered: the cash price at your dose

Does Kaiser Permanente cover Zepbound for sleep apnea?

Kaiser Permanente Washington says the Wegovy pill is generally not covered on its commercial plans and that it covers Ozempic as its semaglutide for listed conditions, including sleep apnea, and for members with a weight-loss rider. In its words: "generally not covered on Kaiser Permanente commercial plans. We cover Ozempic as our semaglutide product for select covered indications, including but not limited to, diabetes, MASH, and OSA, and for members with weight loss rider coverage." (Kaiser Permanente Washington Provider E-News, January 2026, item Wegovy not covered under Kaiser Permanente commercial plans, wa-provider.kaiserpermanente.org, read Nov 17, 2026).

What do Zepbound and Wegovy cost if Kaiser Permanente does not cover them?

Zepbound costs $299/28 days at 2.5 mg and $449/28 days at 15 mg without insurance at Amazon Pharmacy and LillyDirect (Eli Lilly), checked Nov 11, 2026 on pharmacy.amazon.com and zepbound.lilly.com. At 15 mg, the terms: at Amazon Pharmacy, through Dec 31, 2026, with Lilly's self-pay card, whose terms on Lilly's Zepbound savings page say "Card expires and savings end on 12/31/2026" and require each refill within 45 days of the previous delivery, or Lilly's regular $699 applies; at LillyDirect (Eli Lilly), Self Pay Journey price with a refill within 45 days; otherwise $499 at 7.5 mg or $699 at 10 to 15 mg. Wegovy costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked Nov 11, 2026 on pharmacy.amazon.com and novocare.com. Compounded, not FDA-approved: compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year with the membership); compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year with the membership). Every GLP-1's cash price without insurance

Does Medicaid cover Zepbound or Wegovy?

It depends on the state: 10 state programs cover GLP-1s for weight loss, by KFF's January 2026 map and the states' own notices since. Every state's Medicaid answer

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

What a plan covers is decided by the plan and the employer or program behind it, and changes; check your own plan's drug list before you rely on this. This page reports the insurer's own published words and sellers' own prices, not insurance or medical advice. Compounded medications are not FDA-approved. GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.